nVerses Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,700	Closed	-$150K	–	685
2024 Q3	$150K	Buy	2,700 +1,900	+238%	+$106K	0.07%	394
2024 Q2	$32.9K	Buy	+800	New	+$32.9K	0.02%	678